| For: | Ghosn M, Kourie HR, El Rassy E, Haddad FG, Hanna C, El Karak F, Nasr D. Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature. World J Gastrointest Oncol 2016; 8(10): 745-750 [PMID: 27795814 DOI: 10.4251/wjgo.v8.i10.745] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i10/745.htm |
| Number | Citing Articles |
| 1 |
Nedal Bukhari, Eric Winquist. Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review. Case Reports in Oncology 2017; 10(2) doi: 10.1159/000477841
|
| 2 |
Winston Wong, Maeve A. Lowery, Michael F. Berger, Yelena Kemel, Barry Taylor, Ahmet Zehir, Preethi Srinivasan, Chaitanya Bandlamudi, Joanne Chou, Marinela Capanu, Anna Varghese, Kenneth H. Yu, Christine A. Iacobuzio‐Donahue, Jinru Shia, David S. Klimstra, William R. Jarnagin, Zsofia K. Stadler, Eileen M. O’Reilly. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes. Cancer 2019; 125(9) doi: 10.1002/cncr.31951
|
| 3 |
Anurita Srivastava, Phani Kumar Nekarakanti, Sudheer Kanchodu, Siddharth Srivastava, Pramod Kumar Mishra, Sundeep Singh Saluja. Role of adjuvant therapy in resected periampullary adenocarcinoma: A propensity matched case-control study. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(3) doi: 10.14701/ahbps.24-032
|
| 4 |
Jirapat Wonglhow, Panu Wetwittayakhlang, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Arunee Dechaphunkul. Gemcitabine-Based versus Fluoropyrimidine-Based Chemotherapy and Role of Platinum Combination for First-Line Palliative Systemic Treatment in Advanced Ampullary Adenocarcinoma. Cancer Management and Research 2026; doi: 10.2147/CMAR.S608153
|
| 5 |
R Stephen McCain, Helen G Coleman, Claire Jones, Richard C Turkington, Paul Kelly, Andrew McGuigan. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
| 6 |
Molecular pathways in periampullary cancer: An overview. Cellular Signalling 2022; 100 doi: 10.1016/j.cellsig.2022.110461
|
| 7 |
Niraj Kumari, Rajneesh K. Singh, Shravan K. Mishra, Raghvendra L, Samir Mohindra, Narendra Krishnani. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. Pathology - Research and Practice 2021; 217 doi: 10.1016/j.prp.2020.153309
|
| 8 |
Aixin Ou, Xiangxuan Zhao, Zaiming Lu. The potential roles of p53 signaling reactivation in pancreatic cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1) doi: 10.1016/j.bbcan.2021.188662
|
| 9 |
Flavio Roberto Takeda, Ulysses Ribeiro, Fabio Ferrari Makdissi, Marcel Autran Machado, Carlos Frederico Sparapan Marques, Caio Sergio Rizkallah Nahas, Rodrigo Ambar Pinto, Sergio Carlos Nahas. Vascular Surgery in Oncology. 2022; doi: 10.1007/978-3-030-97687-3_3
|
| 10 |
C. Schneider, M.H. Sodergren, T. Pencavel, F. Soggiu, R.H. Bhogal, A.Z. Khan. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma. Surgical Oncology 2020; 35 doi: 10.1016/j.suronc.2020.08.028
|
| 11 |
Lawrence Lau, Nicholas Latchana, Shiva Jayaraman, Sean Cleary, Carol-anne E. Moulton. Surgical Oncology Manual. 2020; doi: 10.1007/978-3-030-48363-0_2
|
| 12 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95 doi: 10.1016/j.intimp.2021.107508
|
| 13 |
Christos Liatsos, Nikos Viazis, Filippos Gkeros, Aris Doukatas, Michail Galanopoulos. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. World Journal of Gastroenterology 2021; 27(24): 3568-3580 doi: 10.3748/wjg.v27.i24.3568
|
| 14 |
Wenhao Luo, Yawen Wang, Yinjie Tao, Taiping Zhang. Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.979390
|
| 15 |
Yue Xue, Serdar Balci, Cisel Aydin Mericoz, Orhun C. Taskin, Hongmei Jiang, Burcin Pehlivanoglu, Takashi Muraki, Bahar Memis, Burcu Saka, Grace E. Kim, Sudeshna Bandopadhyay, Jessica Knight, Bassel F. El‐Rayes, Juan Sarmiento, Michelle D. Reid, Mert Erkan, Olca Basturk, Volkan Adsay. Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated. Cancer 2020; 126(21) doi: 10.1002/cncr.33135
|
| 16 |
Hyung Sun Kim, Woojin Kim, Itaru Endo, Jin‐Young Jang, Hongbeom Kim, Ki Byung Song, Dae Wook Hwang, Chang Moo Kang, Ho Kyoung Hwang, Sang‐Jae Park, Sung‐Sik Han, Yoo‐Seok Yoon, Jae Do Yang, Ryosuke Amano, Sadaaki Yamazoe, Hiroaki Yanagimoto, Tetsuo Ajiki, Masayuki Ohtsuka, Daisuke Suzuki, Dong‐Shik Lee, Yuji Kitahata, Koji Amaya, Jun Sakata, Hyung Il Seo, Junichiro Yamauchi, Yasuhiro Yabushita, Takayuki Tanaka, Naoki Sakurai, Teijiro Hirashita, Akihiko Horiguchi, Michiaki Unno, Dong Do You, Yo‐ichi Yamashita, Shogo Kobayashi, Yusuke Kyoden, Takao Ide, Hiroaki Nagano, Masafumi Nakamura, Hiroki Yamaue, Masakazu Yamamoto, Joon Seong Park. Proposal of nomograms to predict clinical outcomes in patients with ampulla of Vater cancer based on the Korea‐Japan collaborative study. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(3) doi: 10.1002/jhbp.1229
|
| 17 |
Ming‐Xing Xia, Zhi‐Mei Shi, Ling Xing, Dao‐Jian Gao, Xin Ye, Tian‐Tian Wang, Jun Wu, You‐Wen Qian, Wen‐Hao Qin, Bing Hu. Endoscopic radiofrequency ablation may improve overall survival in patients with inoperable ampullary carcinoma. Digestive Endoscopy 2022; 34(3) doi: 10.1111/den.14078
|
| 18 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5) doi: 10.3390/ijms22052655
|
| 19 |
John Silke, Lorraine Ann O’Reilly. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers 2021; 13(18) doi: 10.3390/cancers13184510
|
| 20 |
登基 王. Research Progress in Pancreatic Cancer. Advances in Clinical Medicine 2022; 12(06) doi: 10.12677/ACM.2022.126751
|
| 21 |
Damiano Caputo. Hot topics in pancreatic cancer management. World Journal of Gastrointestinal Surgery 2023; 15(2): 121-126 doi: 10.4240/wjgs.v15.i2.121
Abstract(761) |
Core Tip(844) |
Full Article(HTML)(2407)
|
Full Article (PDF)-637K(277)
|
Full Article (Word)-116K(45)
|
Audio-377K(27)
|
Peer-Review Report-309K(180)
|
Answering Reviewers-78K(130)
|
Times Cited (0)
|
Total Visits (3312)
|
Open
|
| 22 |
Hyung Sun Kim, Jin‐Young Jang, Yoo‐Seok Yoon, Sang‐Jae Park, Wooil Kwon, Sun‐Whe Kim, Ho Seong Han, Sung‐Sik Han, Joon Seong Park, Dong Sup Yoon. Does adjuvant treatment improve prognosis after curative resection of ampulla of Vater carcinoma? A multicenter retrospective study. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(10) doi: 10.1002/jhbp.801
|